Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
04 2022
Historique:
revised: 22 10 2020
received: 17 12 2019
accepted: 03 11 2020
pubmed: 6 11 2020
medline: 6 5 2022
entrez: 5 11 2020
Statut: ppublish

Résumé

The Systemic Lupus International Collaborating Clinics (SLICC) frailty index (FI) predicts mortality and damage accrual in systemic lupus erythematosus (SLE), but its association with hospitalizations has not been described. Our objective was to estimate the association of baseline SLICC-FI values with future hospitalizations in the SLICC inception cohort. Baseline SLICC-FI scores were calculated. The number and duration of inpatient hospitalizations during follow-up were recorded. Negative binomial regression was used to estimate the association between baseline SLICC-FI values and the rate of hospitalizations per patient-year of follow-up. Linear regression was used to estimate the association of baseline SLICC-FI scores with the proportion of follow-up time spent in the hospital. Multivariable models were adjusted for relevant baseline characteristics. The 1,549 patients with SLE eligible for this analysis were mostly female (88.7%), with a mean ± SD age of 35.7 ± 13.3 years and a median disease duration of 1.2 years (interquartile range 0.9-1.5) at baseline. Mean ± SD baseline SLICC-FI was 0.17 ± 0.08. During mean ± SD follow-up of 7.2 ± 3.7 years, 614 patients (39.6%) experienced 1,570 hospitalizations. Higher baseline SLICC-FI values (per 0.05 increment) were associated with more frequent hospitalizations during follow-up, with an incidence rate ratio of 1.21 (95% confidence interval [95% CI] 1.13-1.30) after adjustment for baseline age, sex, glucocorticoid use, immunosuppressive use, ethnicity/location, SLE Disease Activity Index 2000 score, SLICC/American College of Rheumatology Damage Index score, and disease duration. Among patients with ≥1 hospitalization, higher baseline SLICC-FI values predicted a greater proportion of follow-up time spent hospitalized (relative rate 1.09 [95% CI 1.02-1.16]). The SLICC-FI predicts future hospitalizations among incident SLE patients, further supporting the SLICC-FI as a valid health measure in SLE.

Identifiants

pubmed: 33152181
doi: 10.1002/acr.24504
pmc: PMC8096857
mid: NIHMS1644601
doi:

Substances chimiques

Immunosuppressive Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

638-647

Subventions

Organisme : NCRR NIH HHS
ID : M01 RR000046
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000150
Pays : United States
Organisme : Department of Health
Pays : United Kingdom
Organisme : NCRR NIH HHS
ID : UL1 RR025741
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001422
Pays : United States
Organisme : CIHR
ID : MOP-88526
Pays : Canada
Organisme : NIAMS NIH HHS
ID : P30 AR072579
Pays : United States
Organisme : NIAMS NIH HHS
ID : P60 AR064464
Pays : United States
Organisme : NIAMS NIH HHS
ID : P60 AR048098
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR043727
Pays : United States
Organisme : Arthritis Research UK
Pays : United Kingdom
Organisme : NIAMS NIH HHS
ID : K24 AR002138
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2020 American College of Rheumatology.

Références

Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
Cancer. 2015 May 15;121(10):1540-7
pubmed: 25529481
Age Ageing. 2018 Mar 1;47(2):193-200
pubmed: 29040347
J Rheumatol. 2018 Jul;45(7):929-933
pubmed: 29657150
Lancet Neurol. 2019 Feb;18(2):133-134
pubmed: 30663601
J Rheumatol. 2020 Jan;47(1):72-81
pubmed: 30988130
J Infect Dis. 2014 Oct 15;210(8):1170-9
pubmed: 24903667
Arthritis Rheum. 2007 Jan;56(1):265-73
pubmed: 17195230
BMC Geriatr. 2008 Sep 30;8:24
pubmed: 18826625
Arthritis Care Res (Hoboken). 2011 Sep;63(9):1224-32
pubmed: 21584945
J Frailty Aging. 2018;7(4):217-223
pubmed: 30298169
Arthritis Care Res (Hoboken). 2016 Aug;68(8):1128-34
pubmed: 26662554
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
BMC Med. 2018 Sep 21;16(1):171
pubmed: 30236103
Rheumatology (Oxford). 2013 May;52(5):905-9
pubmed: 23307831
Arthritis Rheum. 1999 Apr;42(4):599-608
pubmed: 10211873
Arthritis Rheum. 1993 Nov;36(11):1548-59
pubmed: 8240431
Lupus. 2017 Jun;26(7):756-761
pubmed: 27831537
AIDS. 2015 Aug 24;29(13):1633-41
pubmed: 26372273
J Rheumatol. 2014 Apr;41(4):698-705
pubmed: 24584923
Lupus. 2016 Nov;25(13):1412-1419
pubmed: 27000153
Arthritis Care Res (Hoboken). 2015 Mar;67(3):431-6
pubmed: 25185936
Lupus. 2013 Nov;22(13):1341-8
pubmed: 24048215
J Rheumatol. 1992 Oct;19(10):1559-65
pubmed: 1464868
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):738-43
pubmed: 17634321
Blood. 2018 Feb 1;131(5):515-524
pubmed: 29141942
Interdiscip Top Gerontol. 2015;40:85-98
pubmed: 25341515
Interdiscip Top Gerontol Geriatr. 2015;41:66-73
pubmed: 26301980
CMAJ. 2011 May 17;183(8):E487-94
pubmed: 21540166
Arthritis Care Res (Hoboken). 2020 Dec;72(12):1800-1808
pubmed: 31609532
Semin Arthritis Rheum. 2013 Dec;43(3):352-61
pubmed: 23786872
Lupus. 2000;9(8):601-6
pubmed: 11035435
J Rheumatol. 2017 Aug;44(8):1173-1178
pubmed: 28620060
Arthritis Rheum. 1996 Mar;39(3):363-9
pubmed: 8607884
Arthritis Rheumatol. 2019 Aug;71(8):1297-1307
pubmed: 30771242
Arthritis Rheumatol. 2020 Apr;72(4):658-666
pubmed: 31631584
Best Pract Res Clin Rheumatol. 2012 Oct;26(5):695-704
pubmed: 23218432
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Mech Ageing Dev. 2019 Jun;180:107-116
pubmed: 31002924
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
J Rheumatol. 2002 Feb;29(2):288-91
pubmed: 11838846
Ann Rheum Dis. 2015 Sep;74(9):1706-13
pubmed: 24834926
Age Ageing. 2012 Mar;41(2):142-7
pubmed: 22345294
Lupus Sci Med. 2014 Jun 05;1(1):e000017
pubmed: 25396063
J Am Geriatr Soc. 2005 Dec;53(12):2184-9
pubmed: 16398907
J Rheumatol. 2006 Sep;33(9):1770-4
pubmed: 16832848
Lupus. 2003;12(9):672-6
pubmed: 14514129
Arthritis Care Res (Hoboken). 2018 Sep;70(9):1294-1302
pubmed: 29193883
Biogerontology. 2010 Oct;11(5):547-63
pubmed: 20559726
Arthritis Rheum. 2008 Feb 15;59(2):162-8
pubmed: 18240192

Auteurs

Alexandra Legge (A)

Dalhousie University, Halifax, Nova Scotia, Canada.

Susan Kirkland (S)

Dalhousie University, Halifax, Nova Scotia, Canada.

Kenneth Rockwood (K)

Dalhousie University, Halifax, Nova Scotia, Canada.

Pantelis Andreou (P)

Dalhousie University, Halifax, Nova Scotia, Canada.

Sang-Cheol Bae (SC)

Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.

Caroline Gordon (C)

College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Juanita Romero-Diaz (J)

Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico.

Jorge Sanchez-Guerrero (J)

Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico.

Daniel J Wallace (DJ)

Cedars-Sinai/David Geffen School of Medicine at University of California, Los Angeles.

Sasha Bernatsky (S)

McGill University, Montreal, Quebec, Canada.

Ann E Clarke (AE)

Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Joan T Merrill (JT)

Oklahoma Medical Research Foundation, Oklahoma City.

Ellen M Ginzler (EM)

State University of New York Downstate Medical Center, Brooklyn.

Paul R Fortin (PR)

CHU de Québec-Université Laval, Quebec City, Quebec, Canada.

Dafna D Gladman (DD)

Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.

Murray B Urowitz (MB)

Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.

Ian N Bruce (IN)

University of Manchester, NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, and Manchester Academic Health Science Center, Manchester, UK.

David A Isenberg (DA)

University College London, London, UK.

Anisur Rahman (A)

University College London, London, UK.

Graciela S Alarcón (GS)

University of Alabama at Birmingham.

Michelle Petri (M)

Johns Hopkins University School of Medicine, Baltimore, Maryland.

Munther A Khamashta (MA)

St Thomas' Hospital, King's College London School of Medicine, London, UK.

M A Dooley (MA)

University of North Carolina, Chapel Hill.

Rosalind Ramsey-Goldman (R)

Northwestern University and Feinberg School of Medicine, Chicago, Illinois.

Susan Manzi (S)

Allegheny Health Network, Pittsburgh, Pennsylvania.

Asad A Zoma (AA)

Hairmyres Hospital, East Kilbride, Scotland, UK.

Cynthia Aranow (C)

Feinstein Institute for Medical Research, Manhasset, New York.

Meggan Mackay (M)

Feinstein Institute for Medical Research, Manhasset, New York.

Guillermo Ruiz-Irastorza (G)

BioCruces Bizkaia Health Research Institute, Hospital Universitario Cruces, and University of the Basque Country, Barakaldo, Spain.

S Sam Lim (SS)

Emory University School of Medicine, Atlanta, Georgia.

Murat Inanc (M)

Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.

Ronald F van Vollenhoven (RF)

Karolinska Institute, Stockholm, Sweden.

Andreas Jonsen (A)

Lund University, Lund, Sweden.

Ola Nived (O)

Lund University, Lund, Sweden.

Manuel Ramos-Casals (M)

Hospital Clínic, Barcelona, Spain.

Diane L Kamen (DL)

Medical University of South Carolina, Charleston.

Kenneth C Kalunian (KC)

University of California San Diego School of Medicine, La Jolla.

Søren Jacobsen (S)

Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Christine A Peschken (CA)

University of Manitoba, Winnipeg, Manitoba, Canada.

Anca Askanase (A)

Hospital for Joint Diseases, New York University, New York.

John G Hanly (JG)

Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH